Aggregated
14% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Berenberg
A Berenberg analyst with 7 tracked ratings covering 7 distinct tickers has a 14.3% success rate on the captured sample, focusing exclusively on one source.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| HRMYHARMONY BIOSCIENCES HOLDINGS INC | 2023-09-07 | unknown | $59.00 | Aggregated |
| KRYSKRYSTAL BIOTECH INC | 2023-09-07 | unknown | $154.00 | Aggregated |
| HALOHALOZYME THERAPEUTICS INC. | 2023-03-27 | unknown | $58.00 | Aggregated |
| ASND | 2022-08-30 | buy | $166.00 | Aggregated |
| ASNDASCENDIS PHARMA A/S - ADR | 2022-08-30 | unknown | $166.00 | Aggregated |
| AVXLANAVEX LIFE SCIENCES CORPORATION | 2022-06-23 | unknown | $40.00 | Aggregated |
| DNLIDENALI THERAPEUTICS INC | 2022-06-23 | unknown | $39.00 | Aggregated |
| RGNXREGENXBIO INC | 2022-06-23 | unknown | $61.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| HRMYHARMONY BIOSCIENCES HOLDINGS INC | 1 | 2023-09-07 | Aggregated |
| KRYSKRYSTAL BIOTECH INC | 1 | 2023-09-07 | Aggregated |
| HALOHALOZYME THERAPEUTICS INC. | 1 | 2023-03-27 | Aggregated |
| ASND | 1 | 2022-08-30 | Aggregated |
| ASNDASCENDIS PHARMA A/S - ADR | 1 | 2022-08-30 | Aggregated |
| AVXLANAVEX LIFE SCIENCES CORPORATION | 1 | 2022-06-23 | Aggregated |
| DNLIDENALI THERAPEUTICS INC | 1 | 2022-06-23 | Aggregated |
| RGNXREGENXBIO INC | 1 | 2022-06-23 | Aggregated |